Boston Scientific to Acquire Nalu Medical, Inc.

Boston Scientific entered into a definitive agreement to acquire Nalu Medical, Inc., a privately held medical technology company focused on minimally invasive chronic pain neuromodulation. The deal includes an upfront cash payment of approximately $533 million for the remaining equity not already owned by Boston Scientific, with Boston Scientific expecting closing in the first half of 2026.